11 Lupus Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting Lupus Studies in San Francisco

NCT03487185Recruiting

Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

A randomized controlled trial of 1,500 women to assess whether treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) in pregnancy will result in a reduction in the rate ...

San Francisco, CANA1,500 participantsThe George Washington University Biostatistics Center

View Study Details

NCT07311434Recruiting

Sleep and Morning Wellbeing Study

The study will be a prospective randomized, controlled clinical study. There will be interventional treatment for a total of 30 days. The subjects will complete questionnaires throughout the study at ...

San Francisco, CANA300 participantsAthletic Greens International

View Study Details

NCT03642028Recruiting

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

Post-traumatic stress disorder (PTSD) is a common consequence of combat that can result in trauma-related hyperarousal and sleep disturbances. Poor sleep, one of the most common complaints in Veterans...

San Francisco, CAPHASE4190 participantsVA Office of Research and Development

View Study Details

NCT06581198Recruiting

A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN)

The purpose of this study is to evaluate the efficacy and safety of rapcabtagene autoleucel (administered once following lymphodepletion) versus Standard of Care (SOC) in patients with systemic lupus ...

San Francisco, CAPHASE2179 participantsNovartis Pharmaceuticals

View Study Details

NCT06897930Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

This is a Phase 1b/2, single-arm, open-label, multi-center, clinical study of AZD0120, a CD19/BCMA dual CAR T cell therapy, to evaluate the safety, tolerability, and efficacy in adult participants wit...

San Francisco, CAPHASE1150 participantsAstraZeneca

View Study Details

NCT05538208Recruiting

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

The study is a 1-year 2-part double-blinded placebo controlled 2-arm clinical trial. Treatment arms are (1) MMF dosed as per body-surface area (MMFBSA; 600mg/m2 body surface area per dose about every ...

San Francisco, CAPHASE2105 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT07220525Recruiting

Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation

Whereas the available evidence mostly supports chronic sleep disruption as a risk factor for incident AF, less is known about the near-term risk of a discrete atrial fibrillation (AF) episode followin...

San Francisco, CANA100 participantsUniversity of California, San Francisco

View Study Details

NCT05201469Recruiting

VIBRANT: VIB4920 for Active Lupus Nephritis

This is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in parti...

San Francisco, CAPHASE274 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT05039619Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

This phase II, randomized, double-blind, placebo-controlled study is designed to evaluate the safety, efficacy and pharmacokinetics (PK) of obinutuzumab in adolescent participants (AP) aged 12 to less...

San Francisco, CAPHASE240 participantsHoffmann-La Roche

View Study Details

NCT06874855Recruiting

Lemborexant in Delayed Sleep Phase Syndrome

The purpose of the study is to evaluate whether Lemborexant is more effective than placebo in shortening sleep onset latency in patients with delayed sleep phase syndrome (both type 1 and type 2). Thi...

San Francisco, CAPHASE415 participantsUniversity of California, San Francisco

View Study Details

NCT02431507Recruiting

Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety

The purpose of this study is to determine the safety and feasibility of the Magnap magnetic device in the treatment of obstructive sleep apnea (OSA)....

San Francisco, CANA10 participantsMichael Harrison

View Study Details

About Lupus Clinical Trials in San Francisco

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.

There are currently 11 lupus clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 2,663 participants. Research is being sponsored by The George Washington University Biostatistics Center, Athletic Greens International, VA Office of Research and Development and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lupus Clinical Trials in San Francisco — FAQ

Are there lupus clinical trials in San Francisco?

Yes, there are 11 lupus clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What lupus treatments are being tested?

The 11 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.

Data updated July 18, 2026 from ClinicalTrials.gov